UnitedHealth Group Incorporated (NYSE:UNH) Stake Raised by Park Place Capital Corp

Park Place Capital Corp boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,251 shares of the healthcare conglomerate’s stock after acquiring an additional 74 shares during the quarter. Park Place Capital Corp’s holdings in UnitedHealth Group were worth $2,165,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Delos Wealth Advisors LLC raised its holdings in UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares during the period. True Wealth Design LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $31,000. Red Tortoise LLC grew its stake in UnitedHealth Group by 45.1% during the 1st quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock valued at $36,000 after acquiring an additional 23 shares in the last quarter. Ruedi Wealth Management Inc. grew its stake in UnitedHealth Group by 58.3% during the 1st quarter. Ruedi Wealth Management Inc. now owns 76 shares of the healthcare conglomerate’s stock valued at $38,000 after acquiring an additional 28 shares in the last quarter. Finally, Transcendent Capital Group LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $40,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 3.0 %

UnitedHealth Group stock traded up $17.06 during mid-day trading on Friday, hitting $589.83. The stock had a trading volume of 5,094,041 shares, compared to its average volume of 4,453,607. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $591.54. The stock has a 50-day simple moving average of $514.72 and a two-hundred day simple moving average of $502.99. The company has a current ratio of 0.88, a quick ratio of 0.85 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $542.87 billion, a PE ratio of 36.05, a P/E/G ratio of 1.64 and a beta of 0.59.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same quarter in the prior year, the firm posted $6.14 earnings per share. The company’s quarterly revenue was up 6.4% on a year-over-year basis. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Insider Transactions at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on UNH. Piper Sandler boosted their target price on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. UBS Group boosted their target price on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a report on Thursday, July 18th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, July 19th. Truist Financial upped their price target on UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Finally, Argus upped their price target on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.